NCT00247169View on ClinicalTrials.gov

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2010

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DRUG

progesterone

Micronized progesterone 400mg 1x daily for 10 days/month from menstrual cycle day 16-25

Trial Locations (1)

Unknown

Dept OB/GYN, Med University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00247169 - Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II | Biotech Hunter | Biotech Hunter